These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11972505)

  • 1. Cutaneous reaction to low-molecular-weight heparin.
    Sivakumaran M; Ghosh K
    Br J Haematol; 2002 May; 117(2):257. PubMed ID: 11972505
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed-type hypersensitivity skin reactions to low molecular weight heparins in a pregnant woman.
    Mora A; Belchi J; Contreras L; Rubio G
    Contact Dermatitis; 2002 Sep; 47(3):177-8. PubMed ID: 12492563
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin reactions due to low molecular weight heparin in pregnancy: a strategic dilemma.
    Verdonkschot AE; Vasmel WL; Middeldorp S; van der Schoot JT
    Arch Gynecol Obstet; 2005 Feb; 271(2):163-5. PubMed ID: 15112083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy.
    Maetzke J; Hinrichs R; Staib G; Scharffetter-Kochanek K
    Allergy; 2004 Feb; 59(2):237-8. PubMed ID: 14763948
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed cutaneous reaction to unfractionated heparin, low molecular weight heparin and danaparoid.
    Sivakumaran M; Ghosh K; Munks R; Gelsthorpe K; Tan L; Wood JK
    Br J Haematol; 1994 Apr; 86(4):893-4. PubMed ID: 7802799
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cutaneous reactions to heparin: immunological and clinical aspects].
    Mathelier-Fusade P; Deschamps A; Abuaf N; Leynadier F
    Presse Med; 1995 Feb; 24(6):323-5. PubMed ID: 7899395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-type hypersensitivity to heparins.
    Borch JE; Bindslev-Jensen C
    Allergy; 2004 Jan; 59(1):118-9. PubMed ID: 14674951
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy.
    Schapkaitz E; Jacobson BF
    S Afr Med J; 2007 Dec; 97(12):1255-7. PubMed ID: 18271118
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
    Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J
    Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
    [No Abstract]   [Full Text] [Related]  

  • 10. Birth outcomes in pregnant women treated with low-molecular-weight heparin.
    Sørensen HT; Johnsen SP; Larsen H; Pedersen L; Nielsen GL; Møller M
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):655-9. PubMed ID: 10949230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
    Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Manifestation of Drug Allergy and Hypersensitivity.
    Zalewska-Janowska A; Spiewak R; Kowalski ML
    Immunol Allergy Clin North Am; 2017 Feb; 37(1):165-181. PubMed ID: 27886905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran offers the simplest solution for thromboprophylaxis after orthopaedic surgery in patients allergic to low-molecular-weight heparins.
    Garcia-Ortega P; Asencio J
    Br J Haematol; 2010 Oct; 151(1):84-5. PubMed ID: 20618326
    [No Abstract]   [Full Text] [Related]  

  • 14. Deep vein thrombosis in pregnancy and heparin hypersensitivity.
    Ojukwu C; Jenkinson SD; Obeid D
    Br J Obstet Gynaecol; 1996 Sep; 103(9):934-6. PubMed ID: 8813320
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R; Glässl A; Landthaler M; Stolz W
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed-type skin reaction to the heparin-alternative danaparoid.
    Szolar-Platzer C; Aberer W; Kränke B
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic mechanisms of cutaneous drug reactions.
    Merk HF; Hertl M
    Semin Cutan Med Surg; 1996 Dec; 15(4):228-35. PubMed ID: 9069590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids].
    Figarella I; Barbaud A; Lecompte T; De Maistre E; Reichert-Penetrat S; Schmutz JL
    Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed-type hypersensitivity reaction to heparin.
    Korstanje MJ; Bessems PJ; Hardy E; van de Staak WJ
    Contact Dermatitis; 1989 May; 20(5):383-4. PubMed ID: 2527721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.